Are glucocorticoids DMARDs?

Annals of the New York Academy of Sciences

Volumn 1069, Issue , 2006, Pages 268-274

  Bijlsma, Johannes W J ^a   Hoes, Jos N ^a   Van Everdingen, Amalia A ^a   Verstappen, Suzan M M ^a   Jacobs, Johannes W G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

DMARDs; Erosions; Glucocorticoids; Prednisone; Rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; CORTISONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE;

CONFERENCE PAPER; DISEASE DURATION; DRUG EFFICACY; DRUG INDICATION; HUMAN; JOINT DESTRUCTION; JOINT INJURY; LOW DRUG DOSE; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

EID: 33646468315     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1351.025     Document Type: Conference Paper

References (18)

1. BIJLSMA, J.W.J., M. BOERS, K.G. SAAG & D.E. FURST. 2003. Glucocorticoids in the treatment of early and late RA. Ann. Rheum. Dis. 62: 1033-1037.
2. KLIPPEL, J.H. 2001. Primer on the Rheumatic Diseases. Edition 12. Arthritis Foundation. Atlanta, GA.
3. GERLAG, D.M., J.J. HARINGMAN, T.J.M. SMEETS, et al. 2004. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in RA. Arthritis Rheum. 50: 3783-3791.
4. MEDICAL RESEARCH COUNCIL AND NUFFIELD FOUNDATION. 1954. A comparison of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis. Br. Med. J. 29: 1223-1227.
5. MEDICAL RESEARCH COUNCIL AND NUFFIELD FOUNDATION. 1959. A comparison of prednisolone with aspirin or other analgesics in the treatment of RA. Ann. Rheum. Dis. 18: 173-187.
6. EMPIRE RHEUMATISM COUNCIL. 1957. Multicentre controlled trial comparing cortisone acetate and acetylsalicylic acid in the long-term treatment of rheumatoid arthritis. Ann. Rheum. Dis. 16: 277-289.
7. VAN EVERDINGEN, A.A., J.W. JACOBS, D.R. SIEWERTSZ VAN REESEMA & J.W.J. BIJLSMA. 2002. Low dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease modifying properties and side effects. A double blind placebo controlled clinical trial. Ann. Intern. Med. 136: 1-12.
8. VAN EVERDINGEN, A.A., D.R. SIEWERTSZ VAN REESEMA, J.W.G. JACOBS & J.W.J. BIJLSMA. 2004. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies. Arthritis Rheum. 51: 233-238.
9. JACOBS, J.W.G., A.A. VAN EVERDINGEN, S.M.M. VERSTAPPEN & J.W.J. BIJLSMA. 2006. Followup radiographic data on patients with rheumatoid arthritis who participated in a two-year trial of prednisone therapy or placebo. Arthritis Rheum. 54: 1422-1428.
10. KIRWAN, J.R. ARTHRITIS AND RHEUMATISM COUNCIL. LOW-DOSE GLUCOCORTICOID STUDY GROUP. 1995. The effect of glucocorticosteroids on joint destruction in rheumatoid arthritis. N. Engl. J. Med. 333: 142-146.
11. HICKLING, R et al. 1998. Joint destruction after glucocorticoids is withdrawn in early RA. Br. J. Rheumatol. 37: 930-936.
12. BOERS, M. et al. 1997. Randomised comparison of combined step-down predisolone, methotrexate and sulphasalazine alone in early rheumatoid arthritis. Lancet 350: 309-318.
13. LANDEWÉ, R.B., M. BOERS, A.C. VERHOEVEN, et al. 2002. COBRA combination therapy in patients with early RA: long-term structural benefits of a brief intervention. Arthritis Rheum. 46: 347-356.
14. WASSENBERG, S., R. RAU, P. STEINFELD & H. ZEIDLER. 2005. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 52: 3371-3380.
15. HANSEN, M., J. PODENPHANT, A. FLORESCU, et al. 1999. A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis: clinical benefits and skeletal side effects. Ann. Rheum. Dis. 58: 713-718.
16. CAPELL, A.A., R. NEDHOK, J.A. HUNTER, et al. 2004. Lack of radiological and clinical benefit over 2 years of low dose prednisolone for rheumatoid arthritis: results of randomised trial. Ann. Rheum. Dis. 63: 797-803.
17. KORPELA, M., L. LA ASONEN, P. HANONNEN, et al. 2004. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease modifying antirheumatic drugs. Arthritis Rheum. 50: 2072-2081.
18. COMBE, B. & R. LANDEWÉ. 2005. LULAR recommendations for management of early arthritis. Ann. Rheum. Dis. 64(Suppl III): 19.